The GERN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GERN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The GERN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View GERN Detailed Price Forecast - CNN Money | View GERN Detailed Summary - Google Finance | ||
View GERN Detailed Summary - Yahoo! Finance | View GERN Stock Research & Analysis - Zacks.com |
View GERN Trends & Analysis - Trade-Ideas | View GERN Major Holders - Barrons | ||
View GERN Call Transcripts - NASDAQ | View GERN Breaking News & Analysis - Seeking Alpha | ||
View GERN Annual Report - CompanySpotlight.com | View GERN OTC Short Report - OTCShortReport.com | ||
View GERN Fundamentals - TradeKing | View GERN SEC Filings - Bar Chart | ||
View Historical Prices for GERN - The WSJ | View Performance/Total Return for GERN - Morningstar | ||
View the Analyst Estimates for GERN - MarketWatch | View the Earnings History for GERN - CNBC | ||
View the GERN Earnings - StockMarketWatch | View GERN Buy or Sell Recommendations - MacroAxis | ||
View the GERN Bullish Patterns - American Bulls | View GERN Short Pain Metrics - ShortPainBot.com |
View GERN Stock Mentions - StockTwits | View GERN Stock Mentions - PennyStockTweets | ||
View GERN Stock Mentions - Twitter | View GERN Investment Forum News - Investor Hub | ||
View GERN Stock Mentions - Yahoo! Message Board | View GERN Stock Mentions - Seeking Alpha |
View Insider Transactions for GERN - SECform4.com | View Insider Transactions for GERN - Insider Cow | ||
View GERN Major Holdings Summary - CNBC | View Insider Disclosure for GERN - OTC Markets | ||
View Insider Transactions for GERN - Yahoo! Finance | View Institutional Holdings for GERN - NASDAQ |
View GERN Stock Insight & Charts - FinViz.com | View GERN Investment Charts - StockCharts.com | ||
View GERN Stock Overview & Charts - BarChart | View GERN User Generated Charts - Trading View |
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Posted on Thursday March 21, 2024
Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates.
Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Posted on Tuesday March 19, 2024
FOSTER CITY, Calif., March 19, 2024--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the pricing of an underwritten offering consisting of 41,999,998 shares of its common stock at a price of $3.00 per share and pre-funded warrants to purchase 8,002,668 shares of its common stock. The pre-funded warrants are being sold at a price of $2.999 per pre-funded warrant. All of the securities in the offering are to be sold by Geron. The offering included
Geron, Madrigal Pharmaceuticals jump on good news from FDA
Posted on Friday March 15, 2024
Shares of both Geron (GERN) and Madrigal Pharmaceuticals (MDGL) are soaring after receiving positive news from the Food and Drug Administration. For Geron, an FDA advisory panel backed its blood disorder treatment. For Madrigal, the FDA approved its treatment for a liver disease known as nonalcoholic steatohepatitis, or NASH. Yahoo Finance's Josh Lipton and Julie Hyman discuss the stocks' reaction in the video above. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Stephanie Mikulich.
Stocks to Watch Friday: Adobe, Ulta, Fisker
Posted on Friday March 15, 2024
[**Adobe (ADBE)**](https://www.wsj.com/market-data/quotes/ADBE): The software company's latest results topped forecasts, but guidance for its current quarter [disappointed investors](https://www.wsj.com/livecoverage/stock-market-today-dow-jones-03-15-2024/card/adobe-reports-solid-earnings-but-stock-sinks-after-outlook-underwhelms-investors-fg7wmoXAIxD5cpqyO7v8).